OTC Markets
15:46:35 08/07/2024 BST
5-day change
1st Jan Change
0.0104
USD
+45.14%
0.00%
+5.00%
CardioComm Solutions Inc. : GE Healthcare and CardioComm Solutions, Inc Enter a private label manufacturer agreement
January 15, 2013 at 03:34 pm
January 14, 2012
GE HEALTHCARE AND CARDIOCOMM SOLUTIONS, INC. ENTER A PRIVATE LABEL MANUFACTURER AGREEMENT.
GE Healthcare MARS Cardiac Event Station and MARS Event Station Lite to be the Private Label for Canadian GEMS Sales Through GE Healthcare.
Toronto, Canada - CardioComm Solutions, Inc. ( TSX-
CardioComm Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-30
CI
CardioComm Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
04-30
CI
CardioComm Solutions, Inc. Appoint Robin Black to Board of Directors
02-15
CI
Cardiocomm Solutions, Inc. Announces CFO Changes
01-09
CI
CardioComm Solutions, Inc. Resumes Full Operations Following Cyber Attack
12-14
CI
CardioComm Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-28
CI
CardioComm Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
28/08/23
CI
CardioComm Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
02/08/23
CI
CardioComm Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
02/08/23
CI
CardioComm Solutions, Inc. Announces Executive Changes
30/01/23
CI
CardioComm Solutions, Inc. Confirms Technology Integration Agreement with Utah-Based Carexm LLC
15/12/22
CI
CardioComm Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
29/11/22
CI
CardioComm Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
30/08/22
CI
CardioComm Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
30/05/22
CI
CardioComm Solutions, Inc. Auditor Raises 'Going Concern' Doubt
01/05/22
CI
CardioComm Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
01/05/22
CI
CardioComm Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
29/11/21
CI
Cardiocomm Solutions, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
30/08/21
CI
CardioComm Solutions, Inc. Announces Earnings Results for the First Quarter Ended March 31, 2021
31/05/21
CI
Cardiocomm Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
29/04/21
CI
CardioComm : Reports Issuance of Shares for Debt
08/04/21
MT
CardioComm Solutions, Inc. has Received Approval on an Expanded ISO 13485:2016 Certification in Compliance with the Medical Device Single Audit Program
09/02/21
CI
Cardiocomm Solutions, Inc. Appoints Ms. Josée Bertrand as Chief Financial Officer
11/01/21
CI
CardioComm : Issues Shares to Settle $0.25 Million of Debt
30/12/20
MT
CardioComm Solutions, Inc. Confirms Plans to Develop A Multi-Lead, Wireless, ECG Patch Device for Use in Clinics, Skilled Nursing Facilities, Clinical Trials
23/12/20
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
CardioComm Solutions, Inc. is a Canada-based company, which develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company's specialization is in the software engineering of computer based (ECG) management and reporting software. The software permits physician interpretations of ECGs and supports private and public payer fee-for-service billings. The Companyâs device connectivity and ECG management technologies are used in medical, consumer, clinical research and telemedicine solutions for the recording, transmission, viewing, analyzing, reporting and storage of electrocardiograms, for arrhythmia screening, diagnosis, and management of cardiac patients. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians.
More about the company
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
CARDIOCOMM SOLUTIONS, INC. 
By 
